A recombinant pseudorabies virus expressing TgSAG1 protects against challenge with the virulent Toxoplasma gondii RH strain and pseudorabies in BALB/c mice

Microbes and Infection

Volumn 10, Issue 12-13, 2008, Pages 1355-1362

  Liu, Quan ^a   Gao, Shengyan ^a   Jiang, Li ^a   Shang, Limin ^a   Men, Jingtao ^a,b   Wang, Ze ^a   Zhai, Yujia ^a   Xia, Zhiping ^a   Hu, Rongliang ^a   Zhang, Xichen ^b   Zhu, Xing Quan ^c  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b JILIN UNIVERSITY   (China)

^c SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Immunity; Pseudorabies virus; TgSAG1; Toxoplasma gondii; Vaccine

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; MEMBRANE ANTIGEN; PSEUDORABIES VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE INSERTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDORABIES HERPETOVIRUS; SPLEEN CELL; T LYMPHOCYTE; TH1 CELL; TOXOPLASMA GONDII; VACCINATION; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIBODIES, VIRAL; ANTIGENS, PROTOZOAN; HERPESVIRUS 1, SUID; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; PSEUDORABIES; PSEUDORABIES VACCINES; RECOMBINATION, GENETIC; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; VACCINATION; VACCINES, DNA;

ANIMALIA; MUS; SUID HERPESVIRUS 1; TOXOPLASMA GONDII;

EID: 54849439261     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2008.08.002     Document Type: Article

References (30)

1. Jones J.L., Lopez A., Wilson M., Schulkin J., and Gibbs R. Congenital toxoplasmosis: a review. Obstet. Gynecol. Surv. 56 (2001) 296-305
2. Yuan Z., Gao S., Liu Q., Xia X., Liu X., Liu B., and Hu R. Toxoplasma gondii antibodies in cancer patients. Cancer Lett. 254 (2007) 71-74
3. Montoya J.G., and Liesenfeld O. Toxoplasmosis. Lancet 363 (2004) 1965-1976
4. Tenter A.M., Heckeroth A.R., and Weiss L.M. Toxoplasma gondii: from animals to humans. Int. J. Parasitol. 30 (2000) 1217-1258
5. Bhopale G.M. Development of a vaccine for toxoplasmosis: current status. Microbes Infect. 5 (2003) 457-462
6. Innes E.A., and Vermeulen A.N. Vaccination as a control strategy against the coccidial parasites Eimeria, Toxoplasma and Neospora. Parasitology 133 (2006) S145-S168
7. Darcy F., Maes P., Gras-Masse H., Auriault C., Bossus M., Deslee D., Godard I., Cesbron M.F., Tartar A., and Capron A. Protection of mice and nude rats against toxoplasmosis by a multiple antigenic peptide construction derived from Toxoplasma gondii P30 antigen. J. Immunol. 149 (1992) 3636-3641
8. Wang H., Liu Q., Liu K., Zhong W., Gao S., Jiang L., and An N. Immune response induced by recombinant Mycobacterium bovis BCG expressing ROP2 gene of Toxoplasma gondii. Parasitol. Int. 56 (2007) 263-268
9. Mishima M., Xuan X., Yokoyama N., Igarashi I., Fujisaki K., Nagasawa H., and Mikami T. Recombinant feline herpesvirus type 1 expressing Toxoplasma gondii ROP2 antigen inducible protective immunity in cats. Parasitol. Res. 88 (2002) 144-149
10. Mateus-Pinilla N.E., Dubey J.P., Choromanski L., and Weigel R.M. A field trial of the effectiveness of a feline Toxoplasma gondii vaccine in reducing T. gondii exposure for swine. J. Parasitol. 85 (1999) 855-860
11. Thomsen D.R., Marotti K.R., Palermo D.P., and Post L.E. Pseudorabies virus as a live virus vector for expression of foreign genes. Gene 57 (1987) 261-265
12. Kimman T.G., De Wind N., De Bruin T., de Visser Y., and Voermans J. Inactivation of glycoprotein gE and thymidine kinase or the US3-encoded protein kinase synergistically decreases in vivo replication of pseudorabies virus and the induction of protective immunity. Virology 205 (1994) 511-518
13. Xu G., Xu X., Li Z., He Q., Wu B., Sun S., and Chen H. Construction of recombinant pseudorabies virus expressing NS1 protein of Japanese encephalitis (SA14-14-2) virus and its safety and immunogenicity. Vaccine 22 (2004) 1846-1853
14. Zhang J., He S., Jiang H., Yang T., Cong H., Zhou H., Zhang J., Gu Q., Li Y., and Zhao Q. Evaluation of the immune response induced by multiantigenic DNA vaccine encoding SAG1 and ROP2 of Toxoplasma gondii and the adjuvant properties of murine interleukin-12 plasmid in BALB/c mice. Parasitol. Res. 101 (2007) 331-338
15. Caetano B.C., Bruna-Romero O., Fux B., Mendes E.A., Penido M.L., and Gazzinelli R.T. Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of Toxoplasma gondii induces immune response and protection against infection in mice. Hum. Gene Ther. 17 (2006) 415-426
16. Yang C.D., Chang G.N., and Chao D. Protective immunity against Toxoplasma gondii in mice induced by a chimeric protein rSAG1/2. Parasitol. Res. 92 (2004) 58-64
17. Fachado A., Rodriguez A., Angel S.O., Pinto D.C., Vila I., Acosta A., Amendoeira R.R., and Lannes-Vieira J. Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice. Vaccine 21 (2003) 1327-1335
18. Jestin A., Foulon T., Pertuiset B., Blanchard P., and Labourdet M. Rapid detection of pseudorabies virus genomic sequences in biological samples from infected pigs using polymerase chain reaction DNA amplification. Vet. Microbiol. 23 (1990) 317-328
19. In: Sambrook J., and Russell D.W. (Eds). Molecular Cloning: A Laboratory Manual (2001), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
20. Xiao S.B., Chen H.C., Fang L.R., Niu C.S., Zhang H., and Jiang Y.B. Comparison of immune responses and protective efficacy of suicidal DNA vaccine and conventional DNA vaccine encoding glycoprotein C of pseudorabies virus in mice. Vaccine 22 (2004) 345-351
21. Desolme B., Mevelec M.N., Buzoni-Gatel D., and Bout D. Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene. Vaccine 18 (2000) 2512-2521
22. Salwa A. A natural outbreak of Aujeszky's disease in farm animals. Pol. J. Vet. Sci. 7 (2004) 261-266
23. Zhang G., Huong V.T., Battur B., Zhou J., Zhang H., Liao M., Kawase O., Lee E.G., Dautu G., and Igarashi M. A heterologous prime-boost vaccination regime using DNA and a vaccinia virus, both expressing GRA4, induced protective immunity against Toxoplasma gondii infection in mice. Parasitology 134 (2007) 1339-1346
24. Roque-Resendiz J.L., Rosales R., and Herion P. MVA ROP2 vaccinia virus recombinant as a vaccine candidate for toxoplasmosis. Parasitology 128 (2004) 397-405
25. Yin J., Ren X., Tian Z., and Li Y. Assembly of pseudorabies virus genome-based transfer vehicle carrying major antigen sites of S gene of transmissible gastroenteritis virus: potential perspective for developing live vector vaccines. Biologicals 35 (2007) 55-61
26. Hong Q., Qian P., Li X.M., Yu X.L., and Chen H.C. A recombinant pseudorabies virus co-expressing capsid proteins precursor P1-2A of FMDV and VP2 protein of porcine parvovirus: a trivalent vaccine candidate. Biotechnol. Lett. 29 (2007) 1677-1683
27. Jiang Y., Fang L., Xiao S., Zhang H., Pan Y., Luo R., Li B., and Chen H. Immunogenicity and protective efficacy of recombinant pseudorabies virus expressing the two major membrane-associated proteins of porcine reproductive and respiratory syndrome virus. Vaccine 25 (2007) 547-560
28. Qiu H.J., Tian Z.J., Tong G.Z., Zhou Y.J., Ni J.Q., Luo Y.Z., and Cai X.H. Protective immunity induced by a recombinant pseudorabies virus expressing the GP5 of porcine reproductive and respiratory syndrome virus in piglets. Vet. Immunol. Immunopathol 106 (2005) 309-319
29. Klupp B.G., Hengartner C.J., Mettenleiter T.C., and Enquist L.W. Complete, annotated sequence of the pseudorabies virus genome. J. Virol. 78 (2004) 424-440
30. Souza A.P., Haut L., Reyes-Sandoval A., and Pinto A.R. Recombinant viruses as vaccines against viral diseases. Braz. J. Med. Biol. Res. 38 (2005) 509-522